Articles

AstraZeneca: reinvigorating a UK pharma giant

19th December 2014

AstraZeneca: reinvigorating a UK pharma giantAndrew McConaghie

Lisa Anson, President of AstraZeneca UK & Ireland, talks to pharmaphorum about living through Pfizer's takeover bid and the company's expanding presence in diabetes and respiratory disease.As 2014 draws to... Read more

10 social media events that changed healthcare in 2014

18th December 2014

10 social media events that changed healthcare in 2014Daniel Ghinn

This month, Daniel Ghinn reviews some of the key online happenings that have had an impact on healthcare over the year.The year 2014 has been incredible for social media in... Read more

Tunnah’s musings: Reviewing the health of 2014 on Google

17th December 2014

Tunnah’s musings: Reviewing the health of 2014 on GooglePaul Tunnah

As 2014 draws to a close Paul Tunnah takes a different tack on his review of the year for the pharmaceutical industry, using Google to search for his inspiration on... Read more

Early Access: the ground rules for communicating with physicians and p…

16th December 2014

Early Access: the ground rules for communicating with physicians and patientsHolly Lumgair

How should medical departments, advocacy liaison leaders and communication teams in pharma companies deal with demand for early access to investigational medicines?The last few years have seen a rapid increase... Read more

News

Lilly and Adocia partner on ultra-rapid insulin for diabetes

19th December 2014

Lilly and Adocia partner on ultra-rapid insulin for diabetesLinda Banks

Eli Lilly and French biotech Adocia are to develop an ultra-rapid insulin, BioChaperone Lispro, for type 1 and type 2 diabetes. BioChaperone Lispro is based on Adocia's technology and is... Read more

Pfizer takes muscular dystrophy drug into phase II

19th December 2014

Pfizer takes muscular dystrophy drug into phase IIStaff reporter

Pfizer has started phase II trials of a candidate drug to treat Duchenne muscular dystrophy (DMD) as it plays catch-up with rivals PTC Therapeutics, Prosensa and Sarepta.The pharma giant has... Read more

Australia finally gives cystic fibrosis patients access to Kalydeco

18th December 2014

Australia finally gives cystic fibrosis patients access to KalydecoStaff reporter

After months of wrangling, Australia has listed Vertex' cystic fibrosis (CF) therapy Kalydeco in the Pharmaceutical Benefits Scheme, finally giving patients access to the new drug.Negotiations over pricing of Kalydeco... Read more

Google Ventures increases healthcare investment

17th December 2014

Google Ventures increases healthcare investmentStaff reporter

Google's venture capital division has embarked on a push into healthcare as it follows the lead of its parent company.The fund has directed more than a third of its investments... Read more

Audio & Video

On demand webinar: The Price is Right? -…

Slide-300x200b

 

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the... View more

Now on demand - real world insight into …

The Diabetes Debate

 

Now available on demand (free to access) - originally broadcast on October 29th 2014.


Non-adherence to self-management regimens in diabetes is globally... View more

On-demand webinar: Is pharma brand marke…

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

View the conversation - Tweetchat: Manag…

Atlantis Healthcare diabetes Tweetchat


Working in partnership, Atlantis Healthcare and pharmaphorum conducted a Tweetchat focussed on the real world challenges patients face in managing... View more

White Papers

How do doctors want to engage with pharm…

How do doctors want to engage with pharma on new products?Dr Tim Ringrose

With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to... View info

Modelling patient behaviour to improve s…

Modelling patient behaviour to improve self-management in diabetesDr Sinéad NíMhurchadha & Jeremy Sayers

An understanding of health psychology is essential to helping patients adhere to their medication and lifestyle regimens. This report hones in on how the COM-B model of behaviour provides a... View info

"The future ain’t what it used to b…

"The future ain’t what it used to be"Paul Stuart-Kregor

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there... View info

Healthcare Innovation: the big ideas sha…

Healthcare Innovation: the big ideas shaping the future of pharmaDavid Rowley

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.

Long production cycles, concentration on specialist drugs with high... View info

Further News & Articles

NICE recommends Pfizer's kidney cancer treatment Inlyta

Pfizer is set to gain a NICE recommendation for its renal cell carcinoma treatment Inlyta, two years after it... Read more

News

Experimental Ebola blood therapy trial gets under way

Blood taken from survivors of Ebola could help protect others who contract the deadly disease, as part of a new ... Read more

News

International league tables and medicines

Many people love a good league table; those tables that show you the best schools and universities to study at, t... Read more

Articles

The evolving role of patient advocates at medical congresses

Organisers of medical conferences should include patient advocates on the podium and in the audience as their dir... Read more

Articles

J&J donates new tuberculosis drug

Johnson & Johnson will donate 30,000 doses of its multidrug-resistant tuberculosis (MDR-TB) drug Sirturo to ... Read more

News